Private Female Hormone Blood Tests in the UK (2026): Costs, What's Measured, When to Test, and How to Read the Result

By Aether (AI agent) · Reviewed by our editorial team · Reviewed 9 May 2026 · ~16 min read

Female hormone testing is the most-misordered private blood test in the UK. Not because providers are bad — most are fine — but because the test is uniquely time-dependent. A sample drawn on the wrong day of the menstrual cycle is not a slightly worse data point; it is a different test entirely, and it can be actively misleading. A "low" oestradiol on day 21 is normal. A "high" FSH on day 14 is normal. A "low" progesterone on day 5 is normal. None of these mean what an unsuspecting reader will think they mean.

This guide explains what a female hormone panel actually measures, the cycle-day rules that determine whether your result is meaningful or noise, what UK private providers charge in 2026, who genuinely benefits from private testing (and who should see a GP first), and how to read the result against UK reference bands. For where these tests sit in the wider private-testing market, see our UK blood test provider comparison and UK blood test cost guide. The counterpart for men is our private testosterone blood test guide.

The 90-second answer

What a female hormone blood test actually measures

Female reproductive endocrinology is a feedback loop between the hypothalamus, pituitary and ovaries (the HPO axis). The pituitary releases FSH and LH, which signal the ovaries to mature follicles and release oestradiol. A surge in LH triggers ovulation; the follicle that released the egg becomes the corpus luteum, which makes progesterone for ~14 days. If pregnancy doesn't occur, progesterone falls, the lining sheds, and the cycle restarts. Every marker on a female hormone panel is part of, or affected by, this loop — which is why the day you sample matters so much.

For symptom-led testing, a panel that includes FSH, LH, oestradiol, prolactin, SHBG, testosterone (with FAI), TSH and ideally free T4 is the right level of detail and the level NHS gynaecologists and endocrinologists work from. Medichecks Female Hormone (£79, 9 markers) and Forth Female Hormone (£89, 11 markers including a full thyroid panel) both hit this bracket. AMH is an extra cost on most providers and only worth adding if your question is specifically about fertility / ovarian reserve.

A note on assay quality: oestradiol and testosterone in the female reference range sit at values where immunoassay accuracy degrades. Liquid chromatography–mass spectrometry (LC-MS/MS) is the gold standard. If you're being investigated for very low oestradiol (postmenopause, hypothalamic amenorrhoea, on aromatase inhibitors) or for a precise female testosterone, ask your provider whether they run LC-MS/MS for these markers.

The cycle-timing rules (read this before you order)

This is the single most important section of this guide. Most "abnormal" private female hormone results that arrive in GP surgeries are not abnormal at all — they were sampled on a day where that result is meaningless. Here is the actual rulebook:

If you cannot identify day 1 reliably (very irregular cycles, recent stopping of contraception, post-pregnancy without resumed periods), the right move is usually not to guess and order a private panel. It is to see your GP, who can examine you, take a proper menstrual history, exclude pregnancy, and order the right test at the right time on the NHS. Private testing has a place, but it is not "panel today, answers tomorrow" for women in this situation.

Who genuinely benefits from private female hormone testing?

Female hormone testing is a symptom-led test with a real but narrow set of useful indications. The number alone, without symptoms and without cycle context, is not a diagnosis. Where private testing is reasonable in 2026:

• Suspected PCOS in a woman with irregular or absent periods, hirsutism or acne, or unexplained weight gain. A private day-2–5 panel including FSH, LH, oestradiol, prolactin, SHBG, testosterone, FAI, DHEA-S and TSH is a reasonable shortcut to walk into a GP appointment with usable data. Diagnosis still requires the Rotterdam criteria and an ultrasound.^[2]
• Trying to conceive, with a workup question: have I ovulated this cycle? (day-21 progesterone), what is my ovarian reserve? (AMH), is there a thyroid contribution? (TSH, antibodies), is prolactin raised? Fertility panels at £129–£159 collect these in one go. NHS pathways exist but waits for fertility clinics can be 6–12 months in some areas.
• Premature ovarian insufficiency suspected (under 40 with persistent oligo- or amenorrhoea). POI is underdiagnosed. Two raised FSH measurements 4–6 weeks apart, with low oestradiol, support the diagnosis — this is a GP / endocrinology pathway and HRT is generally indicated until the natural age of menopause. Private testing is reasonable to start the conversation; treatment is not a private DIY pathway.
• Post-pill amenorrhoea (no period 6+ months after stopping hormonal contraception). The differential is broad (PCOS unmasking, hypothalamic, prolactinoma, premature ovarian insufficiency) and a basic panel narrows it.
• Hypothalamic amenorrhoea suspected (athletes, low body fat, restrictive eating, high stress; periods stop). The signature is low LH and FSH with low oestradiol — a different pattern from POI (high LH/FSH) and from PCOS (often raised LH:FSH ratio with normal-to-raised oestradiol). This is a clinical diagnosis with serious bone-density implications and belongs with a GP / specialist.
• HRT monitoring on a self-pay basis if NHS or private clinic monitoring is inadequate, or if you are on testosterone replacement (off-label in the UK) and want to track levels.
• Persistent symptoms not explained by cycle / age in a woman aged 35–45 with a normal NHS thyroid result. A broader private panel can sometimes identify a missed contributor (raised prolactin, low free T, subclinical hypothyroidism with antibodies).

Where private female hormone testing is not the right move:

• Diagnosing perimenopause in a woman aged 45+ with classic symptoms (hot flushes, night sweats, sleep disruption, mood changes, brain fog, period changes). NICE NG23 says this is a clinical diagnosis. A private FSH adds nothing to a confident clinical picture and a "normal" FSH is reassuring in entirely the wrong way — it does not exclude perimenopause.^[1] Spend the £79 on a HRT consultation instead, NHS or private.
• Asymptomatic curiosity testing in women on contraception. The pill suppresses the panel; the result tells you about your contraception, not your underlying hormones.
• Anyone using AMH as a "biological clock countdown". AMH predicts response to IVF stimulation. It does not tell you when you will become infertile, and it should not drive freeze-your-eggs panic on a single number.
• Replacing a GP / menopause specialist consultation. Symptom assessment, cardiovascular risk discussion, family history of breast / endometrial cancer, contraception and bone-health context all matter for HRT decisions. A test report does not replace any of that.

How to read your female hormone result (UK reference bands)

Reference ranges shift dramatically across cycle phases and across life stages, and labs use slightly different assays. The values your report shows alongside your number are the ones to use — but the broad UK bands look like this:

Practical reading rules:

• One result is not a diagnosis. Especially in perimenopause, FSH varies wildly cycle-to-cycle. POI requires two raised samples 4–6 weeks apart, with symptoms.
• Pattern beats single numbers. A raised LH:FSH ratio (often > 2) with low SHBG and raised free androgen index is the classic PCOS biochemical pattern. A single "normal" testosterone does not exclude PCOS — the diagnostic anchor is the Rotterdam criteria, not a hormone number.^[2]
• FSH alone is unreliable in perimenopause. NICE explicitly cautions against using FSH to diagnose perimenopause in women 45+ with typical symptoms. In women under 45 with menopausal-like symptoms, two raised FSH 4–6 weeks apart with amenorrhoea support POI — but the diagnosis is clinical and bone-health follow-up matters.^[1]
• Hypothalamic pattern: low LH, low FSH, low oestradiol in a woman with amenorrhoea, low body fat, high training load or restrictive eating. This is a serious diagnosis (bone density, cardiovascular consequences) and not "your hormones are low, take more vitamin D".
• Markedly raised prolactin (≥ 1000 mIU/L, especially > 2000) warrants pituitary investigation (MRI) regardless of cycle. Mild elevations are common and often medication-related; repeat in the morning, fasted, with no recent breast exam.
• AMH low for age reduces the predicted response to IVF stimulation but does not predict natural conception probability cleanly. It is a planning tool, not a deadline.
• If you're on hormonal contraception, the panel is mostly noise. Stop and wait 2–3 natural cycles before retesting if a baseline is clinically necessary.

What UK private female hormone tests cost in 2026

Verified directly against each provider's UK product page on 9 May 2026. Cycle-day timing and the right panel for the question matter more than absolute price — a £46 panel taken on the wrong day is worse value than a £99 panel taken correctly:

Headline takes (9 May 2026):

• Cheapest verified panel: Randox Female Hormone Quickdraw, £46 — 8 hormones on the painless Tasso upper-arm device. Hard to beat for breadth at this price; no thyroid included though.
• Best clinical-value panel for symptom-led testing: Medichecks Female Hormone Check, £79 — FSH, LH, oestradiol, prolactin, SHBG, testosterone, free androgen index, TSH and free T4. The exact composition a UK GP or gynaecologist would want to see for symptomatic female hormone investigation, with a doctor's report. Forth's £89 panel is similar with a fuller thyroid (adds free T3) — pick on price + ecosystem preference.
• Best for perimenopause "is something happening?" question (under 45): Forth MyFORM® Perimenopause £129 — samples on two cycle days to map the FSH/LH/E2/progesterone pattern rather than relying on a single point-in-time draw. Honest about the variability problem.
• Best for fertility / ovarian reserve question: Medichecks Advanced Female Fertility £159 — full female hormone panel plus AMH. Forth Female Fertility (£144) is similar.
• Best clinic experience: Bluecrest Advanced Menopause Profile, £169 — venous draw in clinic, GP consultation included. The right path if you want a face-to-face conversation about the result before any HRT discussion. Genuinely useful for the "I want to talk to a doctor about my symptoms with data in hand" use case.
• Cheapest single FSH (menopause indication): Bluecrest Menopause Hormone Profile £65 — but a single FSH is the weakest version of this test, and its clinical use case is narrow.

How to prepare for a private female hormone test

Female hormone testing is unusually sensitive to when and how the sample is taken. Most "abnormal" results in well women are protocol failures, not pathology:

• Get the cycle day right. Day 1 = first day of full menstrual bleed (not spotting, not the day before). Sample day 2–5 for FSH/LH/E2/prolactin baselines. Sample day 21 (or 7 days post-ovulation) for progesterone. AMH, SHBG, testosterone, DHEA-S and TSH are not cycle-dependent.
• Morning sample where possible. Prolactin, testosterone and DHEA-S have mild diurnal variation; reference ranges are validated against morning samples.
• Pause biotin supplements for 2 days before testing. Biotin (often in hair / nail / skin multivitamins) interferes with several immunoassay-based hormone measurements and produces falsely high or low readings — a common cause of "weird" private results.
• Avoid testing within 1–2 hours of breast stimulation, recent breast examination, or vigorous exercise. Each transiently raises prolactin.
• Not after acute illness. Wait at least 7–10 days after fever, COVID, flu or any acute illness — acute illness disrupts the HPO axis and you'll get a transiently abnormal result.
• Note any medications. Antipsychotics, metoclopramide, opioids, SSRIs, oestrogens, and some antihypertensives all affect specific markers. A doctor's report from a private provider will only flag what you've told them.
• If on hormonal contraception, accept the panel is uninterpretable for natural-cycle questions. Stop and wait 2–3 natural cycles for a baseline — but discuss with a GP first because contraception is contraception.
• If retesting after an unexpected result — same provider, same time of day, correct cycle day. Different labs use slightly different assays and reference ranges; you cannot compare absolute numbers cleanly across providers. For the full reasoning see UK blood test reference ranges explained.
• Warm hands properly for finger-prick samples — cold fingers don't bleed properly, drops squeezed out forcefully are diluted with tissue fluid, and either contributes to "low" results.

If a result is flagged — the staged pathway

A flagged result is the start of an investigation, not the end. The honest UK pathway in 2026, whether NHS or private:

1. Re-test on the right cycle day if timing was off. If your day-2–5 panel was actually drawn on day 14, the result is meaningless. Re-test correctly before any clinical decision.
2. Repeat any unexpected single result before drawing conclusions. Especially FSH (varies cycle-to-cycle in perimenopause), prolactin (raised by stress, exercise, breast stimulation, sleep), and testosterone (immunoassay accuracy is borderline at female levels).
3. See your NHS GP. Take your private results in. They can examine you, take a proper menstrual history, exclude pregnancy, review medications, and decide whether NHS confirmatory testing or specialist referral is needed. PCOS confirmation requires the Rotterdam framework and a pelvic ultrasound.^[2] POI confirmation requires two raised FSH samples and clinical context. Perimenopause / menopause in women 45+ is a clinical diagnosis based on symptoms — extra FSH testing is not needed in most cases.^[1]
4. HRT decisions belong with a GP or menopause specialist, not a test report. The British Menopause Society and NICE both treat HRT as a structured shared-decision conversation about symptoms, cardiovascular risk, breast/endometrial cancer history, bone health and personal preference.^[3] A finger-prick result does not replace any of that.
5. Fertility flags (low AMH, anovulatory cycles, raised prolactin, abnormal thyroid) get a referral pathway, not a self-treated supplement stack. NHS fertility clinic waits are real, and private fertility clinics exist if NHS criteria don't apply or wait is too long. Either way, this is not "reorder another panel" territory.
6. Address reversible drivers first. In hypothalamic amenorrhoea, that's energy availability, training load, body composition and stress. In PCOS-pattern insulin resistance, it's metabolic — see our HbA1c guide. In thyroid-driven cycle disruption, it's thyroid management — see our thyroid guide. In raised prolactin, it's medication review and — if confirmed and significantly elevated — pituitary imaging.

Red flags that mean see a GP urgently — not a private test

Some symptoms are not "test first, GP later" decisions. They warrant an NHS GP appointment first, with examination and history, because the differential is broader than female hormones:

• Postmenopausal bleeding (any vaginal bleeding 12+ months after the last period). Always investigated. NHS two-week-wait pathway in many areas. The differential includes endometrial cancer; ultrasound and often biopsy follow. A hormone test does not address this.
• Sudden cessation of periods in a woman under 40 (no pregnancy, no contraception change). Could be premature ovarian insufficiency, hypothalamic, prolactinoma, severe weight change, thyroid disease — broader than a private panel resolves.
• Severe pelvic pain with hormone changes, or new heavy unexplained bleeding. GP this week. Differential includes fibroids, endometriosis, ovarian pathology and (rarely) malignancy.
• Galactorrhoea (milky discharge from nipples) outside breastfeeding, especially with cycle changes, headache or visual disturbance. Possible prolactinoma. GP same week. Prolactin testing and pituitary MRI, not a general hormone panel.
• Severe perimenopause symptoms with cardiovascular risk factors (smoker, hypertension, family history of early stroke or heart disease). Get a structured GP / menopause specialist consultation — HRT decisions in higher-risk women are exactly the conversation a private test can't have.
• New-onset hirsutism, voice change, or rapid virilisation. Differential includes androgen-secreting tumours (rare but serious). DHEA-S, testosterone, ultrasound and specialist referral, not a self-ordered panel.
• Suspected pregnancy. A pregnancy test before any hormone testing. Hormone panels in undisclosed early pregnancy are uninterpretable and can delay appropriate care.

FAQ

Should I test before seeing my GP about perimenopause symptoms?

Usually no, if you're 45 or over with classic symptoms (hot flushes, night sweats, sleep disruption, mood changes, brain fog, period changes). NICE NG23 is explicit: this is a clinical diagnosis in women 45+ and FSH testing is not routinely required.^[1] A private FSH adds nothing to a confident clinical picture, and a "normal" FSH on a single day does not exclude perimenopause. Spend the £79 on a HRT consultation (NHS or private) instead. However — if you're under 45 with menopausal-like symptoms, or if your GP is dismissing symptoms you're confident about, a private panel can be a useful way to walk back into the appointment with usable data, especially if it shows raised FSH with low oestradiol on day 2–5.

Why does cycle day matter so much?

Because the markers physiologically change across the cycle. Oestradiol is < 100 pmol/L on day 3 and > 1000 pmol/L on day 13 in the same woman. FSH is 5 IU/L on day 3 and 30+ IU/L mid-cycle. Reference ranges quoted on lab reports assume early-follicular timing for the baseline markers. A "high" FSH from a mid-cycle sample is normal physiology, not pathology. A "low" oestradiol from day 3 is normal physiology, not POI. The number is only meaningful relative to where you are in your cycle.

Can I test while on the pill?

You can — but most of the panel will not be interpretable for questions about your natural cycle. Combined hormonal contraception (pill, patch, ring) suppresses FSH, LH, oestradiol and the natural cycle by design. Progestin-only methods (POP, implant, hormonal IUS) variably suppress some markers. AMH is the main marker that's relatively unaffected. If you need a baseline panel for a clinical question (PCOS workup, suspected POI), the standard advice is to stop hormonal contraception, wait 2–3 natural cycles, and then test on day 2–5 of a natural cycle. Discuss with your GP first — contraception is contraception, and the alternative needs to be in place.

What's the difference between a fertility panel and a female hormone panel?

A "female hormone" panel measures the HPO-axis markers that define how your cycle is working: FSH, LH, oestradiol, prolactin, SHBG, testosterone, FAI, often TSH. A "fertility" panel adds AMH (anti-Müllerian hormone, a marker of ovarian reserve) and sometimes day-21 progesterone (to confirm ovulation) and a fuller thyroid panel. Fertility panels are typically £40–£80 more expensive. If your question is "is my cycle disrupted and why?", a female hormone panel is enough. If your question is "we're trying to conceive and want a fuller workup", a fertility panel is the right level. AMH alone (no other hormones) is sold by some providers for £100–£130 if that's specifically what you want.

Is AMH a good "biological clock" test?

It is and it isn't. AMH reflects the size of your remaining ovarian follicle pool and falls progressively with age — so it broadly correlates with how close you are to menopause, on average, in groups of women. What it does well: predict how ovaries will respond to IVF stimulation; help plan whether to bank eggs / pursue treatment sooner. What it does badly: predict natural fertility in any individual woman this month or next year. A low AMH does not mean you cannot conceive naturally now, and a high AMH does not guarantee future fertility — many other factors (tubal patency, ovulation, sperm quality, age-related egg quality) matter more for natural conception. Treat AMH as a planning tool, not a deadline.

Should I test testosterone if I'm a woman?

Yes, in three scenarios: (1) suspected PCOS — high testosterone with low SHBG and raised free androgen index is the classic biochemical pattern; (2) new hirsutism, virilisation, or voice change — to investigate androgen excess from ovary or adrenal source; (3) persistent low libido in postmenopause not responding to standard HRT — increasingly recognised, and some menopause specialists prescribe testosterone replacement (off-label in the UK) on top of standard HRT. Most UK panels report testosterone against male ranges by default — check that your provider reports female-specific ranges (typical adult female total: 0.3–1.7 nmol/L). LC-MS/MS assay is more accurate at low female levels than immunoassay; ask if precision matters for your question.

How is this different from the menopause blood tests pharmacies offer?

Pharmacy menopause tests (Boots, Superdrug, Lloyds) are generally either (a) urine-based FSH dipstick tests (£10–£20) that detect raised FSH typical of menopause, or (b) finger-prick FSH-only blood tests (£30–£60). Both have the same problem as a private FSH done at the wrong time: FSH varies cycle-to-cycle in perimenopause, and a single normal value does not rule it out. They can be useful as a low-cost confirmation in postmenopausal women confirming amenorrhoea is hormonal, but they are weak tests for the actual diagnostic question most women are asking. A proper female hormone panel (£79–£99 with multiple markers) gives more diagnostic information; the British Menopause Society remains clear that perimenopause / menopause in women 45+ is a clinical diagnosis regardless of what any FSH test says.^[3]

Related buyer's guides

• Best women's health blood test UK — our umbrella guide: which panel actually fits a UK woman across cycling years, fertility, perimenopause and post-menopause, with provider picks and a life-stage decision rubric. The female hormone panel sits at the heart of the cycling-years and fertility sections.
• Menopause blood test UK — the focused menopause cornerstone. What NICE actually says about FSH testing, what to test by life stage, and why over-45 testing is often misleading.
• Private AMH & fertility hormone blood test UK — the deeper dive on AMH (anti-Müllerian hormone), age-banded ovarian reserve ranges, NHS-funded fertility pathway and IVF eligibility. Read this if your specific question is fertility or ovarian reserve rather than general hormone testing.
• Private testosterone blood test UK — the men's-health counterpart to this guide; relevant if you're investigating low T as a contributor to female libido or in PCOS workup.
• Private thyroid blood test UK — thyroid disease mimics nearly every female-hormone symptom; rule out before assuming a hormonal cause.
• Private HbA1c blood test UK — insulin resistance and central adiposity drive low SHBG and the PCOS biochemical pattern; HbA1c is the right second test alongside hormones.
• Private ferritin blood test UK — heavy menstrual bleeding causes iron deficiency, and low ferritin causes fatigue, hair shedding and exercise intolerance independently of hormones.
• Private full blood count (FBC) test UK — paired with ferritin in heavy-bleeding workup; flags anaemia patterns.
• Private cortisol & stress-axis blood test UK — important context for women on oestrogen-containing contraception or HRT, both of which raise total cortisol via CBG without changing biology.
• How to read your blood test results (UK) — general framework for any flagged result.
• UK blood test cost guide — full price landscape across providers and panels.
• Best UK blood test providers compared — our 9-provider comparison with rubric and rankings.
• UK blood test pricing index (open dataset) — provider × test pricing data, free to download.
• LetsGetChecked UK catalogue shrinking, 2026 — investigative piece on category cuts; LGC's female hormone tests survived the cull.

How we wrote this guide

This article was researched and drafted by Aether (an AI agent) and reviewed by a human editorial team before publication. We cite primary UK sources — NICE NG23 (menopause), the Rotterdam consensus criteria for PCOS, and the British Menopause Society — rather than secondary content sites. Provider prices reflect each provider's UK product pages on 9 May 2026 (Randox, Medichecks, Forth, Numan, MyHealthChecked, LetsGetChecked, Bluecrest verified directly; Thriva subscription pricing not directly verifiable). Rankings reflect editorial assessment and are not adjusted for affiliate relationships. Read our editorial process · affiliate disclosure.

Changelog

• 9 May 2026 — Draft v1 published. Initial publication. Randox, MyHealthChecked, Bluecrest, Medichecks, Numan, Forth and LetsGetChecked prices verified live the same day. Thriva price not directly verifiable (sold inside subscription bundles); flagged accordingly in pricing table. Numan prices reflect first-test promotional discount; standard list price varies.

References

1. National Institute for Health and Care Excellence — Menopause: identification and management (NG23). The UK standard for diagnosing perimenopause / menopause in primary care, including the explicit guidance that FSH testing is not routinely required to diagnose perimenopause in women aged 45+ with typical symptoms. nice.org.uk/guidance/ng23
2. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group — Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Hum Reprod 2004;19(1):41–47. The diagnostic framework still in use globally: PCOS requires two of three — oligo/anovulation, clinical/biochemical hyperandrogenism, polycystic ovaries on ultrasound. academic.oup.com
3. British Menopause Society — Tools for clinicians and consensus statements on HRT prescribing. The UK reference for HRT decision-making, framing menopause / perimenopause management as a structured shared-decision conversation rather than a test-driven pathway. thebms.org.uk
4. NHS — Menopause: diagnosis. Patient-facing guidance aligned with NICE NG23. nhs.uk/conditions/menopause
5. European Society of Human Reproduction and Embryology — Management of women with premature ovarian insufficiency. The reference for diagnosing POI: amenorrhoea / oligomenorrhoea under 40 with two FSH measurements > 25 IU/L at least 4 weeks apart. eshre.eu

Disclaimer: This article is general information, not medical advice. We are not medical professionals. Female hormone testing is part of a clinical pathway that requires symptom assessment, examination, cycle history and (where appropriate) specialist input — not a single private test result. Do not start, stop or change HRT, contraception, or any prescribed medication based on a private blood test alone. Perimenopause and menopause are normal life stages, not diseases; treatment decisions depend on symptoms, risk and preference, and should involve a GP or menopause specialist.